Ultrasound, Doppler ,and Calprotectin in Necrotizing Enterocolitis Diagnosis
Necrotizing Enterocolitis
About this trial
This is an interventional diagnostic trial for Necrotizing Enterocolitis
Eligibility Criteria
Inclusion Criteria:
- Include All cases with necrotizing enterocolitis (NEC) in assiut university neonatal intensive care unit (NICU) who are presented with any stage of Bell's stages of necrotising enterocolitis within one year .
I. Suspected disease Mild systemic signs (apnoea, bradycardia, temperature instability) Mild intestinal signs (abdominal distention, gastric residuals, bloody stools) Non-specific or normal radiological signs II. Definite disease Mild to moderate systemic signs Additional intestinal signs (absent bowel sounds, abdominal tenderness) Specific radiologic signs (pneumatosis intestinalis or portal venous air) Laboratory changes (metabolic acidosis, thrombocytopaenia) III. Advanced disease Severe systemic illness (hypotension) Additional intestinal signs (striking abdominal distention, peritonitis) Severe radiological signs (pneumoperitoneum) Additional laboratory changes (metabolic and respiratory acidosis, disseminated intravascular coagulopathy).
Exclusion Criteria:surgical problems other than NEC ,NEC beyond neonatal period.
-
Sites / Locations
Arms of the Study
Arm 1
Experimental
intervention arm
do fecal calprotectin, doppler and ultrasound for each patient